Literature DB >> 35719777

Systemic Melioidosis Presenting as Septic Arthritis.

Vaishnavi Arunpriyandan1, Mayurathan Pakkiyaretnam2, Maheswaran Umakanth3.   

Abstract

Melioidosis is a pyogenic infection that is potentially fatal, caused by the bacterium Burkholderia pseudomallei, which is commonly a soilborne pathogen.It is endemic in the Indian subcontinent, northern Australia, and Southeast Asia. Melioidosis has a wide spectrum of clinical manifestations that can mimic various diseases. Septic arthritis is a rare but well-known clinical presentation. Here, we report a case of an adult presenting with acute knee joint pain and swelling. He was subsequently found to have septic arthritis with other system involvement and diagnosed as a case of melioidosis; he responded well to the treatment.
Copyright © 2022, Arunpriyandan et al.

Entities:  

Keywords:  emerging disease; eradication of melioidosis; melioidosis; septic arthritis; systemic melioidosis

Year:  2022        PMID: 35719777      PMCID: PMC9199561          DOI: 10.7759/cureus.25029

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

Review 1.  Melioidosis.

Authors:  W Joost Wiersinga; Bart J Currie; Sharon J Peacock
Journal:  N Engl J Med       Date:  2012-09-13       Impact factor: 91.245

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Risk factors for recurrent melioidosis in northeast Thailand.

Authors:  Direk Limmathurotsakul; Wipada Chaowagul; Wirongrong Chierakul; Kasia Stepniewska; Bina Maharjan; Vanaporn Wuthiekanun; Nicholas J White; Nicholas P J Day; Sharon J Peacock
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

Review 4.  Melioidosis as an emerging global problem.

Authors:  D A Dance
Journal:  Acta Trop       Date:  2000-02-05       Impact factor: 3.112

5.  Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei.

Authors:  Sharon J Peacock; Herbert P Schweizer; David A B Dance; Theresa L Smith; Jay E Gee; Vanaporn Wuthiekanun; David DeShazer; Ivo Steinmetz; Patrick Tan; Bart J Currie
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

6.  Increasing incidence of human melioidosis in Northeast Thailand.

Authors:  Direk Limmathurotsakul; Surasakdi Wongratanacheewin; Nittaya Teerawattanasook; Gumphol Wongsuvan; Seksan Chaisuksant; Ploenchan Chetchotisakd; Wipada Chaowagul; Nicholas P J Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

7.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

8.  Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.

Authors:  Allen C Cheng; Wirongrong Chierakul; Wipada Chaowagul; Ploenchan Chetchotisakd; Direk Limmathurotsakul; David A B Dance; Sharon J Peacock; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.